# Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.

> **NCT03472170** · NA · UNKNOWN · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 120 (estimated)

## Conditions studied

- SEPSIS SYNDROME

## Interventions

- **DIETARY_SUPPLEMENT:** Enteral administration of bovine lactoferrin (bLf)
- **OTHER:** Enteral administration of placebo

## Key facts

- **NCT ID:** NCT03472170
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-04
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03472170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03472170, "Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03472170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*